Furthermore, NEPAL risk scores were also significantly associated with several hallmarks of advanced PCa 46-48, namely AR-V, cell cycle progression, MYC targets, proliferation and stemness, whereas conversely linked to androgen response and luminal features (Figure 6E). The gene discussed is MYC; the disease is posterior cortical atrophy.